Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Salee Industry Public Company Limited (SALEE.BK)
Pathum Thani, TH
Salee Industry Public Company Limited, along with its associated companies, produces and supplies various plastic products, components, implements, and machinery both within Thailand and globally. Their manufacturing operations utilize injection moulding and vacuum pressure forming techniques for plastic components, in addition to producing self-adhesive and paper labels. Key industries they cater to include electronics, automotive, food packaging, hard disk drives, and general electronic parts packaging. Established in 1993, the company's headquarters are located in Pathum Thani, Thailand.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.28% | +34.09% | +55.26% | +55.26% | +55.26% | +63.89% | +55.26% | -40.40% | -49.57% | -43.81% | -70.79% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+11.2% ★ Q1'26: +5.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+416.3% ★ Q1'26: +41.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+6.0% Q1'26: +4.3% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+2.3% Q1'26: +6.2% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+2.7% Q1'26: +6.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: -0.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.14× ★ Q1'26: 0.08× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2011 actual |
Dec 2012 actual |
|---|---|---|
| Revenue |
744.29M
est: 1.01B (-26.2%)
|
1.05B
est: 1.11B (-5.5%)
|
| EBITDA |
197.02M
est: 124.93M (+57.7%)
|
336.90M
est: 137.41M (+145.2%)
|
| EBIT |
130.50M
est: 21.84M (+497.5%)
|
274.04M
est: 24.02M (+1,040.8%)
|
| Net Income |
66.74M
|
166.45M
|
| SGA |
130.40M
est: 193.92M (-32.8%)
|
157.80M
est: 213.30M (-26.0%)
|
| EPS |
0.05
|
0.11
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 2/5 | 5/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 5/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 2/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sathit Tatawatorn | Chairman of Executive Committee, Acting MD & Director | — | male |
| Siriwan Panjamatum | Financial & Accounting Director | — | female |
| Suchart Chivapornthip | Executive Director | — | male |
| Supoj Soontarinka | Director of IR & Information Technology, Company Secretary, Executive Director and Director | — | male |
| Takashi Otani | Marketing & Sales Senior Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SALEE.BK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
